EMEA-003543-PIP01-23
Submitted by Anonymous (not verified) on 10 June 2025 - 15:27
EMEA-003543-PIP01-23
Human medicines European public assessment report (EPAR): Vokanamet, canagliflozin,metformin, Date of authorisation: 23/04/2014, Revision: 25, Status: Authorised
Submitted by Anonymous (not verified) on 10 June 2025 - 15:22
Human medicines European public assessment report (EPAR): Vokanamet, canagliflozin,metformin, Date of authorisation: 23/04/2014, Revision: 25, Status: Authorised
EMEA-003542-PIP01-23
Submitted by Anonymous (not verified) on 10 June 2025 - 15:20
EMEA-003542-PIP01-23
EMEA-003443-PIP02-23
Submitted by Anonymous (not verified) on 10 June 2025 - 15:03
EMEA-003443-PIP02-23
EMEA-003551-PIP01-23
Submitted by Anonymous (not verified) on 10 June 2025 - 14:55
EMEA-003551-PIP01-23
Human medicines European public assessment report (EPAR): Apexelsin, paclitaxel, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 10 June 2025 - 14:45
Human medicines European public assessment report (EPAR): Apexelsin, paclitaxel, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised
EMEA-003457-PIP01-23
Submitted by Anonymous (not verified) on 10 June 2025 - 14:43
EMEA-003457-PIP01-23
Minutes of the COMP meeting 14-15 April 2025
Submitted by Anonymous (not verified) on 10 June 2025 - 14:40
Minutes of the COMP meeting 14-15 April 2025
QRD Appendix V - Adverse-drug-reaction reporting details
Submitted by Anonymous (not verified) on 10 June 2025 - 14:33
QRD Appendix V - Adverse-drug-reaction reporting details
EMEA-003395-PIP02-23
Submitted by Anonymous (not verified) on 10 June 2025 - 14:21
EMEA-003395-PIP02-23